Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 82332 | 28.0028 |
09:34 ET | 6253 | 27.94 |
09:36 ET | 4688 | 27.88 |
09:38 ET | 5460 | 27.93 |
09:39 ET | 5337 | 27.96 |
09:41 ET | 2659 | 27.98 |
09:43 ET | 2708 | 27.96 |
09:45 ET | 3943 | 27.92 |
09:48 ET | 9032 | 27.84 |
09:50 ET | 3939 | 27.87 |
09:52 ET | 5127 | 27.86 |
09:54 ET | 5640 | 27.78 |
09:56 ET | 4408 | 27.72 |
09:57 ET | 4118 | 27.73 |
09:59 ET | 1659 | 27.71 |
10:01 ET | 3344 | 27.775 |
10:03 ET | 3106 | 27.735 |
10:06 ET | 12625 | 27.71 |
10:08 ET | 4229 | 27.695 |
10:10 ET | 5616 | 27.705 |
10:12 ET | 4500 | 27.69 |
10:14 ET | 1883 | 27.705 |
10:15 ET | 1362 | 27.69 |
10:17 ET | 5700 | 27.69 |
10:19 ET | 4592 | 27.71 |
10:21 ET | 4172 | 27.725 |
10:24 ET | 1105 | 27.73 |
10:26 ET | 1755 | 27.74 |
10:28 ET | 3663 | 27.73 |
10:30 ET | 2377 | 27.73 |
10:32 ET | 10265 | 27.735 |
10:33 ET | 200 | 27.735 |
10:35 ET | 4414 | 27.775 |
10:37 ET | 5155 | 27.7642 |
10:39 ET | 6660 | 27.795 |
10:42 ET | 5319 | 27.7811 |
10:44 ET | 3060 | 27.785 |
10:46 ET | 4168 | 27.77 |
10:48 ET | 830 | 27.79 |
10:50 ET | 800 | 27.795 |
10:51 ET | 1684 | 27.82 |
10:53 ET | 2007 | 27.85 |
10:55 ET | 6418 | 27.85 |
10:57 ET | 1859 | 27.85 |
11:00 ET | 3657 | 27.865 |
11:02 ET | 2074 | 27.84 |
11:04 ET | 300 | 27.845 |
11:06 ET | 2210 | 27.845 |
11:08 ET | 5085 | 27.85 |
11:09 ET | 1245 | 27.855 |
11:11 ET | 2299 | 27.85 |
11:13 ET | 3683 | 27.8401 |
11:15 ET | 4472 | 27.83 |
11:18 ET | 1174 | 27.835 |
11:20 ET | 5539 | 27.845 |
11:22 ET | 200 | 27.85 |
11:24 ET | 6373 | 27.83 |
11:26 ET | 2903 | 27.815 |
11:27 ET | 4309 | 27.825 |
11:29 ET | 2951 | 27.84 |
11:31 ET | 3205 | 27.865 |
11:33 ET | 4235 | 27.8476 |
11:36 ET | 2097 | 27.86 |
11:38 ET | 5281 | 27.865 |
11:40 ET | 588 | 27.875 |
11:42 ET | 1814 | 27.865 |
11:44 ET | 2821 | 27.875 |
11:45 ET | 300 | 27.88 |
11:47 ET | 3389 | 27.87 |
11:49 ET | 2441 | 27.875 |
11:51 ET | 300 | 27.845 |
11:54 ET | 600 | 27.84 |
11:56 ET | 163 | 27.8311 |
11:58 ET | 4395 | 27.83 |
12:00 ET | 2289 | 27.81 |
12:02 ET | 306 | 27.815 |
12:03 ET | 2813 | 27.81 |
12:07 ET | 13649 | 27.795 |
12:09 ET | 4142 | 27.81 |
12:12 ET | 1430 | 27.805 |
12:14 ET | 932 | 27.805 |
12:16 ET | 4017 | 27.795 |
12:18 ET | 2308 | 27.795 |
12:20 ET | 1600 | 27.795 |
12:21 ET | 7660 | 27.81 |
12:23 ET | 2232 | 27.815 |
12:25 ET | 4063 | 27.795 |
12:27 ET | 3549 | 27.835 |
12:30 ET | 2241 | 27.8 |
12:32 ET | 753 | 27.8 |
12:34 ET | 600 | 27.82 |
12:36 ET | 200 | 27.825 |
12:38 ET | 2810 | 27.845 |
12:39 ET | 4795 | 27.845 |
12:41 ET | 600 | 27.845 |
12:43 ET | 2185 | 27.835 |
12:45 ET | 2737 | 27.84 |
12:48 ET | 3740 | 27.825 |
12:50 ET | 200 | 27.825 |
12:52 ET | 3678 | 27.81 |
12:54 ET | 200 | 27.815 |
12:56 ET | 3504 | 27.83 |
12:57 ET | 600 | 27.825 |
12:59 ET | 35227 | 27.775 |
01:01 ET | 4341 | 27.77 |
01:03 ET | 1510 | 27.775 |
01:06 ET | 700 | 27.775 |
01:08 ET | 11709 | 27.805 |
01:10 ET | 8466 | 27.7911 |
01:12 ET | 1100 | 27.8 |
01:14 ET | 3364 | 27.805 |
01:15 ET | 2936 | 27.8 |
01:17 ET | 5702 | 27.81 |
01:19 ET | 800 | 27.815 |
01:21 ET | 1933 | 27.815 |
01:24 ET | 8289 | 27.805 |
01:26 ET | 5844 | 27.815 |
01:28 ET | 700 | 27.815 |
01:30 ET | 4129 | 27.795 |
01:32 ET | 5383 | 27.805 |
01:33 ET | 8663 | 27.805 |
01:35 ET | 1234 | 27.805 |
01:37 ET | 3335 | 27.815 |
01:39 ET | 497 | 27.815 |
01:42 ET | 2056 | 27.815 |
01:44 ET | 5929 | 27.815 |
01:46 ET | 3509 | 27.825 |
01:48 ET | 1498 | 27.83 |
01:50 ET | 500 | 27.825 |
01:51 ET | 2511 | 27.835 |
01:53 ET | 2240 | 27.835 |
01:55 ET | 9901 | 27.8229 |
01:57 ET | 8886 | 27.8 |
02:00 ET | 3840 | 27.81 |
02:02 ET | 3058 | 27.8 |
02:04 ET | 1980 | 27.795 |
02:06 ET | 13980 | 27.805 |
02:08 ET | 4932 | 27.805 |
02:09 ET | 1123 | 27.805 |
02:11 ET | 4277 | 27.805 |
02:13 ET | 1526 | 27.815 |
02:15 ET | 3862 | 27.815 |
02:18 ET | 4015 | 27.815 |
02:20 ET | 1100 | 27.81 |
02:22 ET | 11922 | 27.815 |
02:24 ET | 5260 | 27.805 |
02:26 ET | 900 | 27.805 |
02:27 ET | 1400 | 27.805 |
02:29 ET | 1000 | 27.805 |
02:31 ET | 9941 | 27.785 |
02:33 ET | 8481 | 27.795 |
02:36 ET | 3991 | 27.815 |
02:38 ET | 883 | 27.82 |
02:40 ET | 1324 | 27.815 |
02:42 ET | 7098 | 27.81 |
02:44 ET | 15910 | 27.818 |
02:45 ET | 3000 | 27.82 |
02:47 ET | 3600 | 27.845 |
02:49 ET | 4350 | 27.865 |
02:51 ET | 2831 | 27.855 |
02:54 ET | 3440 | 27.875 |
02:56 ET | 11581 | 27.835 |
02:58 ET | 7878 | 27.845 |
03:00 ET | 5064 | 27.83 |
03:02 ET | 9364 | 27.815 |
03:03 ET | 1491 | 27.815 |
03:05 ET | 11938 | 27.795 |
03:07 ET | 10478 | 27.799 |
03:09 ET | 5819 | 27.8 |
03:12 ET | 23326 | 27.77 |
03:14 ET | 1796 | 27.755 |
03:16 ET | 2577 | 27.765 |
03:18 ET | 923 | 27.765 |
03:20 ET | 6884 | 27.77 |
03:21 ET | 8612 | 27.7567 |
03:23 ET | 3177 | 27.775 |
03:25 ET | 852 | 27.765 |
03:27 ET | 4384 | 27.775 |
03:30 ET | 1920 | 27.76 |
03:32 ET | 3892 | 27.745 |
03:34 ET | 3083 | 27.745 |
03:36 ET | 8607 | 27.725 |
03:38 ET | 1622 | 27.705 |
03:39 ET | 3385 | 27.71 |
03:41 ET | 7179 | 27.685 |
03:43 ET | 5955 | 27.685 |
03:45 ET | 4526 | 27.695 |
03:48 ET | 6612 | 27.68 |
03:50 ET | 14950 | 27.705 |
03:52 ET | 39929 | 27.635 |
03:54 ET | 18442 | 27.65 |
03:56 ET | 34933 | 27.605 |
03:57 ET | 70786 | 27.615 |
03:59 ET | 2634038 | 27.54 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.3B | 18.3x | +1.83% |
Amneal Pharmaceuticals Inc | 2.7B | -14.0x | --- |
Endo Inc | 2.0B | 0.4x | --- |
Catalent Inc | 10.9B | -10.4x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 19.0x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 3.05% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.3x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 19.5x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.